ArticleEJNMMI physics2026
Multi-modal segment anything model (mmSAM) for tumor segmentation in multi-tracer oncologic PET/CT.
Article in EJNMMI physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeLesion segmentation is important in targeted radionuclide therapy dosimetry. In this study, we proposed a novel 2D multi-modal Segment Anything Model (mmSAM) for lesion segmentation in whole-body multi-tracer PET/CT images.
methodsThe AutoPET 2024 dataset, including
resultsmmSAM achieved the best performance as compared to other segmentation methods for the primary
conclusionThe proposed mmSAM is promising for lesion segmentation in multi-tracer oncologic PET/CT images. Fine-tuning significantly enhances segmentation accuracy for cross-tracer studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.